1/394
Looks like no tags are added yet.
MS: Definition
Autoimmune CNS disease causing inflammatory demyelination and axonal transection; disrupts white-matter conduction.
MS: Diagnostic framework
Dissemination of lesions in space and time, supported by MRI T2 lesions and CSF oligoclonal bands.
MS: Dissemination in space
Evidence of damage in at least 2 separate CNS areas.
MS: Dissemination in time
Evidence of damage at 2 distinct points in time, at least 1 month apart.
MS: Pathophysiology cascade
T-cells cross BBB → oligodendrocyte death → B-cell cytokines → inflammation → demyelination → remyelination → plaque.
MS: Acute inflammatory phase
Focal areas of demyelination and inflammation in CNS white matter.
MS: Chronic phase
Remyelination, inflammation that resolves without repair, or ongoing smoldering activity.
MS: Demyelination
Slows or blocks conduction; function may partially recover.
MS: Axonal transection
Permanent damage that drives long-term disability.
MS: Why heat worsens MS
Poorly myelinated segments conduct marginally; increased body temperature can temporarily worsen symptoms.
MS: Peripheral nerve involvement
MS targets CNS oligodendrocytes/myelin and generally spares peripheral nerves.
MS: Typical age of onset
Young adults, typically ages 20-30.
MS: Sex prevalence
Women are affected more often than men.
MS: US prevalence
About 900,000 people.
MS: Genetic risk
Family clustering and HLA-DRB1*15:01 allele.
MS: Lifestyle/environment risks
Childhood obesity, cigarette smoking, Epstein-Barr virus, and higher latitudes/colder climates.
MS: Common neurologic/motor findings
Optic neuritis, gait and motor deficits, sensory deficits, brainstem syndromes, ataxia, and spasticity.
MS: Other common findings
Fatigue, heat intolerance, cognitive dysfunction, depression, sexual dysfunction, and bowel/bladder issues.
MS: Clinically isolated syndrome (CIS)
Single first episode that does not yet meet dissemination-in-space and -time criteria.
MS: Relapsing-remitting (RRMS)
Relapses followed by recovery to or near baseline; disability is relatively flat between relapses.
MS: Secondary progressive (SPMS)
Begins as RRMS, then transitions to steady worsening.
MS: Primary progressive (PPMS)
Steady worsening from onset without distinct relapses.
MS: Progressive relapsing (PRMS)
Steady worsening from onset with superimposed relapses and stepwise rises.
MS: Most common course at onset
RRMS; about 85% of cases.
MS: PPMS proportion
Roughly 10-15%.
MS: Preventing relapses
Disease-modifying therapies (DMTs).
MS: Treating acute relapses
High-dose systemic steroids.
MS: Symptom management
Address spasticity, fatigue, cognitive dysfunction, and bladder problems.
MS: Lifestyle management
Avoid heat, increase physical activity, and stop smoking.
MS: Prognostic factors
Sex, age, symptoms, disease course, neurologic findings at 5 years, and MRI findings.
MS: Generally favorable prognosis features
Female sex, younger onset, sensory/optic onset, relapsing course, and low MRI lesion load.
MS PT: Four common problem areas
Fatigue, gait/balance deficits, spasticity, and ataxia.
MS PT: ICF framework
Health condition → body function/structure impairment → activity limitation → participation restriction; include environmental and personal factors.
MS EDGE gait measures
MSWS-12, 6-Minute Walk Test (6MWT), and Timed 25-Foot Walk (T25FW).
MS EDGE balance measures
Berg Balance Scale, Dizziness Handicap Inventory (DHI), and cognitive/manual dual-task TUG.
MS EDGE UE dexterity measure
9-Hole Peg Test.
MS EDGE quality-of-life measures
MS Impact Scale (MSIS-29) and MS Quality of Life-54 (MSQoL-54).
MS Functional Composite
Combines T25FW, 9-Hole Peg Test, and a cognitive processing test (PASAT).
FSMC
20-item self-report measure of motor and cognitive fatigue in MS; free.
MFIS
21-item measure of fatigue impact on physical, cognitive, and psychosocial function over the past 4 weeks; costs money.
MS spasticity measures
No MS EDGE recommendation; use Modified Ashworth Scale (MAS) or Tardieu.
MS ataxia tests
No MS EDGE recommendation; use finger-to-nose, heel-to-shin, and dysdiadochokinesia.
Tardieu vs MAS
Tardieu tests at multiple speeds and better separates velocity-dependent spasticity from contracture.
MS PT treatment considerations
Heat can worsen weakness/fatigue; medications may add fatigue; inactivity causes deconditioning/obesity; depression and sleep disruption are common.
MS PT goals
Optimize independence, safety, quality of life, activity, and respiratory function; provide equipment, community resources, and education.
MS FES evidence
May provide an orthotic effect, improve gait quality, and reduce falls; studies did not consistently improve walking speed or endurance.
MS endurance training evidence
Can improve mobility, depression, fatigue, cognitive function, strength, and anxiety.
MS progressive resistance evidence
24 weeks/48 sessions improved strength and physical/neuromuscular function; one study found increased cortical thickness.
MS inspiratory muscle training
Compared with deep breathing, improved maximal inspiratory and expiratory pressures.
MS BWSTT/RAGT evidence
Studies found improvements in walking speed, endurance, double-limb support, disability, and/or 6MWT; RAGT may reduce fall risk during training.
MS TENS evidence
Improved gastrocnemius EMG activity and tone, reduced spasms, and reduced central pain.
MS tDCS evidence
Improved mood, cognitive processing speed, fatigue, and pain.
MS focal muscle vibration
May improve gait by reducing spasticity; also associated with less pain and better quality of life.
Balance sensory systems
Vestibular, visual, and somatosensory input are integrated by the brainstem, cerebellum, and cerebral cortex.
Vestibular input
Provides equilibrium, spatial awareness, rotation, and linear-movement information.
Visual input
Provides sight for balance and orientation.
Somatosensory input
Provides proprioception and touch information.
Brainstem role in balance
Integrates and sorts sensory information.
Cerebellum role in balance
Coordinates and regulates posture, movement, and balance.
Vestibulo-ocular reflex (VOR)
Controls eye movement to stabilize gaze during head movement.
Vestibulospinal pathways
Produce postural adjustments.
Vestibular dysfunction prevalence
Up to 35% of US adults age 40+ (about 69 million) have experienced dysfunction.
Dizziness in adults 65+
About 80% have experienced dizziness.
BPPV prevalence
Most common vestibular disorder; causes about 50% of dizziness in older adults.
Vestibular diagnosis pathway
Patients see an average of 4-5 physicians before diagnosis.
Vestibular rehabilitation therapy (VRT)
Exercise-based program to reduce vertigo/dizziness, improve gaze stability, and reduce imbalance and falls.
Peripheral vestibular causes
BPPV, vestibular neuritis, labyrinthitis, Meniere disease, vestibular neuroma, and superior canal dehiscence/fistula.
Central dizziness causes
Brainstem/cerebellar stroke, concussion, TBI/diffuse axonal injury, and migraine.
Non-vestibular dizziness causes
Cervicogenic dizziness, orthostatic hypotension, vertebral artery insufficiency, hypoglycemia, and psychiatric causes.
Vestibular neuritis vs labyrinthitis
Neuritis affects the vestibular nerve without hearing loss; labyrinthitis involves the labyrinth and may include hearing loss.
History framework for dizziness
Assess tempo, symptoms, and circumstances.
Acute dizziness
Symptoms lasting 3 days or less.
Chronic dizziness
Symptoms lasting more than 3 days.
Episodic dizziness
Spells lasting seconds, minutes, or hours.
Vertigo
Illusion of movement of self or environment, often spinning, from imbalance of neural activity.
Disequilibrium
Imbalance or unsteadiness while standing or walking; may reflect visual, vestibular, or proprioceptive deficits.
Lightheadedness
Feeling faint or about to pass out, often from temporarily reduced cerebral blood flow.
Motion sickness
Dizziness, fatigue, pallor, sweating, nausea, and sometimes vomiting during passive locomotion from visual-vestibular mismatch.
Oscillopsia
Objects appear to bounce in the visual field; usually associated with bilateral vestibular loss.
Mal de debarquement
Rocking/swaying sensation that can persist for days after a long sea or air trip.
Visual motion sensitivity
Dizziness provoked by full-field moving or patterned visual stimuli; usually central dysfunction.
Common visual symptoms in vestibular patients
Blurred/double vision and light sensitivity.
Common auditory symptoms in vestibular patients
Hearing loss, difficulty hearing, ear fullness, or sound sensitivity.
BPPV history clue
Room spins with sudden head movement, especially rolling or turning in bed; brief true vertigo.
Bilateral vestibular hypofunction history clue
Oscillopsia and constant imbalance.
Unilateral vestibular hypofunction history clue
Dizziness with head turns or turning around while standing.
Orthostatic hypotension history clue
Dizziness when standing up, especially first thing in the morning.
Central dysfunction history clue
Visual motion sensitivity, often after concussion/TBI or with other central pathology.
Vestibular history: circumstances
Ask about standing after lying, lying/sitting up, turning in bed, bending, looking up, exertion, or spontaneous symptoms.
Other vestibular history items
Falls, ADL impact/avoidance, patient beliefs, headaches/migraines, neck/joint pain, and medications.
Vestibular exam: usual first step
Begin with the oculomotor examination unless history strongly suggests BPPV.
Vestibular exam: BPPV exception
If history suggests BPPV, perform positional testing first because BPPV can make other vestibular/oculomotor findings inaccurate.
Ambient light testing
Allows visual fixation.
Frenzel/infrared goggles
Blur or remove fixation to reveal peripheral nystagmus.
Why goggles are used
Visual fixation suppresses peripheral nystagmus; central nystagmus is not suppressed and may be visible in room light.
Peripheral vs central spontaneous nystagmus
Peripheral nystagmus may appear only with fixation removed; spontaneous nystagmus in room light with other central signs warrants medical referral.
Oculomotor central tests
Smooth pursuit, saccades, vergence/convergence, and VOR cancellation.
Normal smooth pursuit
Smooth tracking with minimal symptoms.
Abnormal smooth pursuit
Delays or saccadic intrusions; may indicate central dysfunction.
Normal saccades
Target reached in 1-2 eye movements with minimal symptoms.